IP Library Granted Patent US 11,998,263
Granted Patent B2
US 11,998,263 · App. 17/984,199 · Granted Jun 4, 2024

Methods and devices for treating pelvic conditions

Inventors: Edwin J. Hlavka (Minneapolis, MN); Thomas V. Ressemann (Edina, MN); Eric Whitbrook (St. Paul, MN); John Christian Knudson (Minnetonka, MN)
Assignee: Hologic, Inc.
A61B18/1485A61N1/0514A61N1/36007A61B2018/00291A61B2018/00434A61B2018/00523A61B2018/00577A61B2018/00815A61B2018/00821A61B2018/00982A61B2018/1467A61B2018/1475A61B18/1815A61B2218/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,998,263
App. No.
17/984,199
Granted
Jun 4, 2024
Kind
B2
Abstract

An ablation instrument comprises an elongate shaft having a cannula channel and a scope channel, and an electrode disposed in the cannula channel. The electrode is slidable between a first position in which a distal end of the electrode is contained within the cannula channel, and a second position in which the distal end of the electrode extends out of a distal opening of the cannula channel. The ablation instrument further comprises a distal head coupled to the elongate shaft and configured for contacting solid tissue.

Claims (24)

1. An ablation instrument, comprising:

an elongate shaft having a cannula channel and a scope channel;

an electrode disposed in the cannula channel, wherein the electrode is slidable between a first position in which a distal end of the electrode is contained within the cannula channel, and a second position in which the distal end of the electrode extends out of a distal opening of the cannula channel;

a distal head coupled to the elongate shaft and configured for contacting solid tissue; and

a positioning feature fixed to the distal head and extending from the distal head a fixed distance, wherein the positioning feature is configured to provide a visual reference for determining a distance between the distal head and a uretic bladder ostium as seen through a scope deployed through the scope channel, wherein when the electrode is in the second position and in solid tissue and activated, the uretic bladder ostium will not be adversely affected.

2. The ablation instrument of claim 1 , wherein the positioning feature is a hoop.

3. The ablation instrument of claim 2 , wherein the hoop is made of a flexible material and configured to be atraumatic to solid tissue.

4. The ablation instrument of claim 1 , wherein the positioning feature is selected from the group comprising a pointer, cross hairs, a circle, and a wedge.

5. The ablation instrument of claim 1 , wherein the distal head and the elongate shaft are sized and shaped for insertion into a urethra of a human patient.

6. The ablation instrument of claim 1 , wherein the elongate shaft further comprises a suction channel, and wherein the distal head is a suction head that comprises a plurality of suction apertures in fluid communication with the suction channel, wherein the suction apertures are arranged to hold solid tissue when suction is applied.

7. The ablation instrument of claim 1 , wherein the solid tissue that the distal head is configured for contacting is uterine tissue.

8. The ablation instrument of claim 1 , further comprising a handle assembly attached to the elongate shaft, wherein the handle assembly includes a sliding mechanism shaped to receive and manipulate a scope.

9. The ablation instrument of claim 1 , wherein the positioning feature has an aperture within which the uretic bladder ostium may be located for visualization by a scope deployed through the scope channel, such that the positioning feature provides the visual reference for determining the distance between the distal head and the uretic bladder ostium as seen through a scope deployed through the scope channel.

10. The ablation instrument of claim 9 , wherein the uretic bladder ostium may be centered in the aperture of the positioning feature.

11. The ablation instrument of claim 1 , wherein the positioning feature has a profile that is narrower than a profile of the distal head.

12. The ablation instrument of claim 1 , wherein the positioning feature lies substantially in a plane parallel to a longitudinal axis of the distal head.

13. The ablation instrument of claim 1 , wherein the positioning feature is configured to be positioned between the uretic bladder ostium and the distal head.

14. The ablation instrument of claim 13 , wherein the solid tissue is target tissue that the distal head is configured for ablating when contacting the target tissue.

15. The ablation instrument of claim 1 , wherein the elongate shaft further comprises a suction channel, wherein the distal head comprises a suction face comprising a plurality of suction apertures in fluid communication with the suction channel, wherein the suction apertures are arranged to hold solid tissue when suction is applied, and wherein the scope channel extends at a non-zero angle α to the suction face.

16. The ablation instrument of claim 15 , wherein the distal head comprises an angled face comprising at least one of the suction apertures.

17. The ablation instrument of claim 15 , wherein the angle α is in the range of 4 to 10 degrees.

18. The ablation instrument of claim 15 , wherein the scope channel is oriented at a non-zero angle relative to the cannula channel.

19. The ablation instrument of claim 15 , wherein the suction face is tilted, and the scope channel and the cannula channel are parallel to each other.

20. The ablation instrument of claim 15 , wherein the suction face is tilted at least 5 degrees forward.

Assignments (5)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 065286/0407 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE PRODESSE, INC.
Reel/Frame 075457/0767 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 19, 2023
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 065286/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2022
From: HLAVKA, EDWIN J.; RESSEMANN, THOMAS V.; WHITBROOK, ERIC; KNUDSON, JOHN CHRISTIAN
To: AMPHORA MEDICAL, INC.
Reel/Frame 061914/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2022
From: AMPHORA MEDICAL, INC.
To: HOLOGIC, INC.
Reel/Frame 061914/0822 →